Vertical-specific guidance for medical practice PR.

Why specialty practices stopped buying patient acquisition ads.

The shift is well documented at the practice-management level even though the trade press has been slow to report it. Specialty practices that historically allocated large fractions of their marketing budgets to Google Search ads, Facebook ads, and paid lead-generation services have been reducing those allocations and redirecting the spend toward editorial coverage. The reasons cluster around three observations.

The first is that paid patient acquisition has become more expensive. Cost-per-click in specialty verticals (cardiology, plastic surgery, orthopedics, dermatology, fertility) has risen at compounding rates as the channels have matured and as larger health systems entered the auction. Practices report cost-per-acquired-patient figures that have doubled or tripled over five years on the same campaigns.

The second is that the patients arriving through paid channels convert at lower clinical-yield rates than referred patients. The patient who clicks a Facebook ad is a different patient, with a different relationship to the practice and a different likelihood of pursuing the recommended course of care, than the patient referred by a primary-care physician or by another patient. Practices that measure both channels carefully tend to find the cost-per-completed-treatment is multiples higher for ad-acquired patients.

The third is that editorial coverage produces referrals from referring physicians, who do not click on Facebook ads. The referring-physician channel is the highest-yield channel for most specialty practices and has been historically underdeveloped. Editorial coverage is one of the few interventions that meaningfully moves the referring-physician channel.

HIPAA-aware editorial.

Editorial coverage of a medical practice operates under HIPAA’s Privacy Rule and the FTC’s endorsement guidelines under 16 CFR Part 255. The combination is more constraining than most editorial PR contexts. The constraints break into four categories.

No identifiable patient information. The HIPAA Privacy Rule restricts what a covered entity can say about a patient. Even with patient authorization, editorial pieces should run de-identified case discussion under the HIPAA Safe Harbor framework. The PR Summit drafts patient narrative as anonymized composite where appropriate and runs full Safe Harbor de-identification on any specific case material.

FTC endorsement compliance.Patient testimonials reused from editorial coverage in the practice’s marketing trigger FTC endorsement disclosure rules under 16 CFR Part 255. The disclosure required depends on the relationship between the patient and the practice. Editorial pieces that include patient quotes should be drafted with the reuse case in mind.

FDA-compliant claims.Any reference to a treatment, device, or drug needs to fall within the FDA’s framework on health claims. Editorial copy that strays into off-label use, comparative claims, or efficacy claims that exceed the FDA-approved label creates compliance exposure for the practice. The PR Summit reviews every draft for claim language with the practice’s compliance lead before pitch.

State medical board advertising rules. Most state medical boards have specific advertising rules that overlay HIPAA and FTC. The rules vary significantly by state. Practices in California, Texas, Florida, and New York operate under stricter advertising review than the median.

The publications that drive patient-evaluation reading.

For consumer-facing patient-evaluation reading. The New York Times Health section. The Wall Street Journal Personal Health column and Health desk. Forbes Health (staff-side, not contributor). Time Health. The major regional dailies’ health sections. National Public Radio health features. These are read by patients during the deliberation phase before they choose a specialist.

For referring-physician reading. Modern Healthcare. Medical Economics. Becker’s Hospital Review. Healthcare Finance News for hospital-system leadership. STAT News for life sciences and clinical practice. Vertical clinical trade publications (Cardiology Today, Dermatology Times, Orthopedics This Week, etc.) for specialty-specific coverage. Referring physicians read these to keep current on the field and to identify specialists they trust to send patients to.

For elective specialty practices (aesthetic, fertility, integrative medicine). Tier-1 lifestyle features in Town & Country, Vogue Wellness, Architectural Digest profiles for practice-leadership pieces, Robb Report for HNW patient audiences. The reader audience here overlaps with the practice’s prospective patient demographic.

How long compliance review actually takes.

Editorial PR for a specialty practice runs longer than for a non-medical client because compliance review takes real time. The PR Summit plans for thirty to forty-five days from engagement start to publication, with the compliance window adding ten to twenty days that other verticals do not have.

The compliance workflow runs through three reviewers in series. Practice-side legal or compliance counsel reviews the pitch and draft against HIPAA, FTC, and state-board rules. Medical leadership at the practice (a managing physician or medical director) reviews the clinical content for accuracy and on-label framing. The PR Summit’s editorial team reviews the publication-side fit and revises any language that the publication will likely reject. Each pass takes three to seven days. Two passes per draft is typical.

Practices new to editorial PR sometimes underestimate this window and book engagements with timelines that do not allow for compliance review. The result is rushed review or shipped articles that the practice’s compliance counsel later flags. Better to plan the longer window from the start.

What earned coverage delivers that paid never will.

Three outcomes are characteristic of earned editorial coverage in this vertical and rare or impossible from paid acquisition.

The first is referrals from other physicians. A piece in Modern Healthcare or in a vertical clinical trade publication that names the practice as a category leader gets read by referring physicians in adjacent specialties. The referrals that follow are higher-yield, higher-trust, and longer-tenured than ad-acquired patients.

The second is board credibility. Editorial coverage in respected medical publications counts toward the practice leadership’s board-recognition file in ways that ad spend never does. Practices building toward leadership in a specialty society or on a hospital-system board accumulate editorial track record over years.

The third is malpractice insurer risk-adjustment. Some specialty malpractice insurers offer rate adjustments to practices with documented editorial standing in the field, on the theory that practices recognized as category leaders have lower complaint and claim rates. The adjustments are small in any given year but compound over the practice’s lifetime.